{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06019481",
            "orgStudyIdInfo": {
                "id": "DB-100-001"
            },
            "organization": {
                "fullName": "Regeneron Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations",
            "officialTitle": "A Retrospective and Prospective Natural History Study to Examine the Characteristics of Gene-Related Hearing Loss in Pediatric Participants With Biallelic Otoferlin (OTOF) Mutations, Gap Junction Beta 2 (GJB2) Mutations, Or Digenic GJB2/Gap Junction Beta 6 (GJB6) Mutations",
            "acronym": "ENSEMBLE",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-natural-history-study-in-pediatric-participants-with-hearing-loss-due-to-otof-or-mutations"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-11-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-21",
            "studyFirstSubmitQcDate": "2023-08-25",
            "studyFirstPostDateStruct": {
                "date": "2023-08-31",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-04",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Regeneron Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is an observational study to examine the characteristics of gene-related hearing loss in pediatric participants with biallelic otoferlin (OTOF) Mutations, Gap Junction Beta 2 (GJB2) Mutations, or Digenic GJB2/Gap Junction Beta 6 (GJB6) Mutations. This study will follow the participant for 4 years with annual visits each year.",
            "detailedDescription": "Former Sponsor Decibel Therapeutics\n\nThis is a longitudinal, retrospective and prospective, low interventional study designed to collect data on the natural history of pediatric participants with OTOF, GJB2, or GJB2/GJB6 gene mutations to assess hearing-related outcomes, auditory skills, and speech perception. No investigational product will be administered. At study visits, participants will undergo physiological and behavioral assessments of hearing and vestibular function. Additionally, parents/legal guardians or participants will complete questionnaires that will include the capture of epidemiologic, quality-of-life, auditory and language development, and health resource utilization information."
        },
        "conditionsModule": {
            "conditions": [
                "Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)",
                "Biallelic Mutations in the Gap Junction Beta 2 (GJB2) Gene",
                "Digenic Mutations in GJB2/Gap Junction Beta 6 (GJB6) Genes"
            ],
            "keywords": [
                "Congenital Hearing Loss",
                "Sensorineural Hearing Loss",
                "Auditory Neuropathy",
                "Pediatric",
                "Cochlear Implant",
                "Otoferlin",
                "GJB2",
                "GJB6",
                "OTOF",
                "Deaf",
                "Hard of hearing",
                "Hearing impaired",
                "Hearing disorder",
                "Fully implantable hearing aid",
                "Child",
                "Infant",
                "ENSEMBLE",
                "Gap Junction Beta 6 Genes",
                "Gap Junction Beta 2 Genes"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Hearing-related outcomes",
                    "description": "Auditory brainstem response (ABR) intensity",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Hearing-related outcomes",
                    "description": "Otoacoustic emission (OAEs) amplitudes",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Hearing-related outcomes",
                    "description": "Pure tone intensity thresholds",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Hearing-related outcomes",
                    "description": "Speech detection and perception thresholds.",
                    "timeFrame": "4 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Auditory skills and speech perception over time",
                    "description": "Open- and Closed- set Task phoneme accuracy and word comprehension",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Auditory skills and speech perception over time",
                    "description": "Early Speech Perception (ESP)",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Auditory skills and speech perception over time",
                    "description": "Pediatric Speech Intelligibility (PSI) test",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Auditory skills and speech perception over time",
                    "description": "Auditory Skills Checklist (ASC)",
                    "timeFrame": "4 years"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Quality of life over time",
                    "description": "Quality of Life-Cochlear Implant (QoL-CI) score",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Quality of life over time",
                    "description": "Pediatric Quality of Life (PedsQL) Generic Core Scales dimension and total score",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Quality of life over time",
                    "description": "Hearing Environments and Reflection on Quality of Life (HEAR-QL-26) subscale and overall score",
                    "timeFrame": "4 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participant is no older than 7 years (inclusive) at the time of the parent/legal guardian signing the informed consent form (ICF)\n* Participant has 1 of the following genotypes and meets the associated audiologic criteria based on physiologic and/or behavioral measures of inner ear function:\n* Biallelic pathogenic or likely pathogenic OTOF mutations with severe to profound sensorineural hearing loss (SNHL; \u2265 85 dB HL) and confirmed presence of OAEs\n* Biallelic pathogenic and truncating GJB2 mutation(s) with moderate or moderately-severe SNHL (\u226441 to \\<71 dB HL)\n* Digenic pathogenic or likely pathogenic mutations in GJB2 and GJB6 genes with mild or worse SNHL (\\>26 dB HL)\n* Participant has at least 1 ear that has not received a cochlear implant (CI)\n\nExclusion Criteria:\n\n* History of or active participation in an interventional trial related to hearing loss\n* History or presence of any other permanent/untreatable hearing loss conditions, including genetic conditions other than those involving biallelic OTOF or GJB2 mutations, or digenic GJB2/GJB6 mutations\n* History of treatment with ototoxic drugs",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "7 Years",
            "stdAges": [
                "CHILD"
            ],
            "studyPopulation": "Pediatric participants no older than 7 years, inclusive, who have genetic hearing loss due to OTOF, GJB2, or GJB2/GJB6 mutations.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trials Administrator",
                    "role": "CONTACT",
                    "phone": "844-734-6643",
                    "email": "clinicaltrials@regeneron.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Trial Management",
                    "affiliation": "Regeneron Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Phoenix Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mark E. Gerber, MD",
                            "role": "CONTACT",
                            "phone": "602-933-4134",
                            "email": "mgerber1@phoenixchildrens.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Nationwide Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43205",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ursula Findlen, Ph.D.",
                            "role": "CONTACT",
                            "phone": "614-722-6526",
                            "email": "Ursula.Findlen@nationwidechildrens.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Patients, Caregivers \\& Healthcare Providers: Contribute to Genetic Hearing Loss Research",
                    "url": "https://portal.sanogenetics.com/study/genetic-hearing-loss-trials"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000034381",
                    "term": "Hearing Loss"
                },
                {
                    "id": "D000003638",
                    "term": "Deafness"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006311",
                    "term": "Hearing Disorders"
                },
                {
                    "id": "D000004427",
                    "term": "Ear Diseases"
                },
                {
                    "id": "D000010038",
                    "term": "Otorhinolaryngologic Diseases"
                },
                {
                    "id": "D000012678",
                    "term": "Sensation Disorders"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "relevance": "LOW"
                },
                {
                    "id": "M24420",
                    "name": "Hearing Loss",
                    "asFound": "Hearing Loss",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6840",
                    "name": "Deafness",
                    "asFound": "Hearing Loss",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9407",
                    "name": "Hearing Loss, Sensorineural",
                    "relevance": "LOW"
                },
                {
                    "id": "M9400",
                    "name": "Hearing Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7601",
                    "name": "Ear Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12961",
                    "name": "Otorhinolaryngologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15490",
                    "name": "Sensation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "T547",
                    "name": "Auditory Neuropathy Spectrum Disorder",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC09",
                    "name": "Ear, Nose, and Throat Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}